| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YJMCC.2011.02.008 |
| P698 | PubMed publication ID | 21354172 |
| P50 | author | Antonio Zaza | Q57130638 |
| P2093 | author name string | Marcella Rocchetti | |
| Matteo Alemanni | |||
| Daniele Re | |||
| P2860 | cites work | The inotropic effect of cardioactive glycosides in ventricular myocytes requires Na+-Ca2+ exchanger function | Q24680113 |
| Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes | Q28364342 | ||
| Integrative analysis of calcium cycling in cardiac muscle | Q34101069 | ||
| Regulation of cardiac muscle Ca2+ release channel by sarcoplasmic reticulum lumenal Ca2+ | Q34169317 | ||
| Macromolecular complexes regulating cardiac ryanodine receptor function. | Q35846632 | ||
| Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels | Q36497439 | ||
| The sarcoplasmic reticulum and arrhythmogenic calcium release | Q37002270 | ||
| Overview of emerging pharmacologic agents for acute heart failure syndromes | Q37086309 | ||
| Regulation of current flow through ryanodine receptors by luminal Ca2+. | Q41602511 | ||
| Quantitative assessment of the SR Ca2+ leak-load relationship | Q44167973 | ||
| Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744). | Q44186043 | ||
| Diverse toxicity associated with cardiac Na+/K+ pump inhibition: evaluation of electrophysiological mechanisms. | Q44329151 | ||
| Ouabain increases sarcoplasmic reticulum calcium release in cardiac myocytes | Q44666460 | ||
| Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride]. | Q45171504 | ||
| Modulation of sarcoplasmic reticulum function by PST2744 [istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride)] in a pressure-overload heart failure model | Q46163987 | ||
| Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure | Q46556129 | ||
| Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias | Q47903909 | ||
| Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase | Q48628901 | ||
| Modulation of CICR has no maintained effect on systolic Ca2+: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes. | Q52082843 | ||
| Differential distribution and regulation of mouse cardiac Na+/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. | Q54361992 | ||
| Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). | Q54429273 | ||
| ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology | Q55050673 | ||
| Increasing Ryanodine Receptor Open Probability Alone Does Not Produce Arrhythmogenic Calcium Waves | Q60182017 | ||
| The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes | Q60182042 | ||
| An estimate of the calcium content of the sarcoplasmic reticulum in rat ventricular myocytes | Q60182097 | ||
| Kinetics of [Ca]i decline in cardiac myocytes depend on peak [Ca]i | Q72491683 | ||
| Sarcoplasmic reticulum Ca content, sarcolemmal Ca influx and the genesis of arrhythmias in isolated guinea-pig cardiomyocytes | Q73561281 | ||
| Relative importance of SR load and cytoplasmic calcium concentration in the genesis of aftercontractions in cardiac myocytes | Q74271632 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 910-918 | |
| P577 | publication date | 2011-02-23 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity | |
| P478 | volume | 50 |
| Q41878275 | Digoxin and adenosine triphosphate enhance the functional properties of tissue-engineered cartilage |
| Q37269322 | Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor. |
| Q42008108 | Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition. |
| Q41472411 | Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium |
| Q36527731 | Istaroxime: A rising star in acute heart failure |
| Q42014726 | SERCA2a stimulation by istaroxime: a novel mechanism of action with translational implications |
| Q92588956 | Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials |
Search more.